Acquisitions (Notes)

9 Months Ended

Sep. 30, 2017

Business Combinations [Abstract]

Business Combination Disclosure [Text Block]

3. Acquisitions

On August 8, 2017, the Company acquired all of the outstanding shares of StratAcuity Staffing Partners, Inc. ("Stratacuity") headquartered in New Hampshire for $25.9 million. Stratacuity was purchased to expand the Company's specialized clinical/scientific staffing solutions for biotechnology and pharmaceutical organizations. Goodwill related to this acquisition totaled $17.5 million and is deductible for income tax purposes. Identifiable intangible assets related to this acquisition totaled $7.6 million. The results of operations for this acquisition have been combined with those of the Company from the acquisition date and are included in the Apex Life Sciences business within the Apex Segment.

Assets and liabilities of the acquired entity were recorded at their estimated fair values as of the acquisition date. The excess purchase price over the fair value of net tangible assets and identifiable intangible assets acquired has been allocated to goodwill. The fair value assigned to identifiable intangible assets was determined primarily by using a discounted cash flow method (a non-recurring fair value measurement based on Level 3 inputs). The Company's allocation of the purchase price remains incomplete and any purchase price allocation adjustments will be recognized in the period the adjustments are determined.